Citation
Grobman, William A.; Thom, Elizabeth A.; Spong, Catherine Y.; Iams, Jay D.; Saade, George R.; Mercer, Brian M.; Tita, Alan T. N.; Rouse, Dwight J.; Sorokin, Yoram; & Wapner, Ronald J., et al. (2012). 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Nulliparas with Cervical Length Less than 30 mm. American Journal of Obstetrics & Gynecology, 207(5), 390.e1-8. PMCID: PMC3484249Abstract
OBJECTIVE: We sought to evaluate whether 17 alpha-hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nulliparous women with a midtrimester cervical length (CL) <30 mm.STUDY DESIGN: In this multicenter randomized controlled trial, nulliparous women with a singleton gestation between 16 and 22 3/7 weeks with an endovaginal CL <30 mm (<10th percentile in this population) were randomized to weekly intramuscular 17-OHP (250 mg) or placebo through 36 weeks. The primary outcome was PTB <37 weeks.
RESULTS: The frequency of PTB did not differ between the 17-OHP (n = 327) and placebo (n = 330) groups (25.1% vs 24.2%; relative risk, 1.03; 95% confidence interval, 0.79-1.35). There also was no difference in the composite adverse neonatal outcome (7.0% vs 9.1%; relative risk, 0.77; 95% confidence interval, 0.46-1.30).
CONCLUSION: Weekly 17-OHP does not reduce the frequency of PTB in nulliparous women with a midtrimester CL <30 mm.
URL
http://dx.doi.org/10.1016/j.ajog.2012.09.013Reference Type
Journal ArticleYear Published
2012Journal Title
American Journal of Obstetrics & GynecologyAuthor(s)
Grobman, William A.Thom, Elizabeth A.
Spong, Catherine Y.
Iams, Jay D.
Saade, George R.
Mercer, Brian M.
Tita, Alan T. N.
Rouse, Dwight J.
Sorokin, Yoram
Wapner, Ronald J.
Leveno, Kenneth J.
Blackwell, Sean C.
Esplin, M. Sean
Tolosa, Jorge E.
Thorp, John M., Jr.
Caritis, Steve N.
VanDorsten, J. Peter, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network